Dr. Brian Warrington Joins Phoenix IP Ventures LLC as a Venture Partner.PHILADELPHIA, & Hartford, England -- Phoenix IP Ventures (Phoenix IPV IPV poliovirus vaccine inactivated. IPV abbr. inactivated poliovirus vaccine IPV see infectious pustular vulvovaginitis. ) is pleased to announce that Dr. Brian Warrington Ph.D., CSci, CChem, FRSC FRSC Fellow of the Royal Society of Canada FRSC Fellow of the Royal Society of Chemistry (formerly the Royal Institute of Chemistry) FRSC Federal Road Safety Commission (Nigeria) has formally joined the Phoenix IPV team as a Venture Partner. In this role, Dr. Warrington will provide leadership for certain Phoenix IPV platform technology transactions, utilizing his profound and deep knowledge of research and development processes within the pharmaceutical industry and his connections within the life sciences sector. In addition, Dr. Warrington will act as a main interface for Phoenix IPV's UK-based clients and activities. Osagie Imasogie, Senior Managing Partner Phoenix IPV, stated that, "Brian has worked with members of the Phoenix IPV Partnership over many years and over many transactions, and our team has a deep respect for the value of his insight and ability to 'connect the dots' in a complex and technologically based industry. Having Brian join our team as a Venture Partner will greatly enhance the scientific, commercial and other value propositions Phoenix IPV already brings to our portfolio of companies and clients. His excellent scientific expertise and good judgment is matched only by the quality of his high character, which we have grown to know well over time." "This is an exciting new prospect for me and an opportunity to work with colleagues whose vision, creativity and expertise in the field of venturing and developing IP value I have always regarded with the greatest admiration and respect," said Dr. Warrington. Dr. Warrington recently retired from his position as Vice President, UK Technology Development, for GlaxoSmithKline Discovery Research and has co-founded BB Consultants Ltd, a Life Sciences consulting company Noun 1. consulting company - a firm of experts providing professional advice to an organization for a fee consulting firm business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a based in the UK. Dr. Warrington holds a Ph.D. from the University of London For most practical purposes, ranging from admission of students to negotiating funding from the government, the 19 constituent colleges are treated as individual universities. Within the university federation they are known as Recognised Bodies , is a Fellow of the Royal Society Fellow of the Royal Society is an honour accorded to distinguished scientists and a category of membership of the Royal Society. Fellows are entitled to put the letters FRS after their name. Up to 44 new fellows are elected each year by ballot of the existing fellows. of Chemistry, a Chartered Scientist Chartered Scientist (CSci) is a professional qualification in the United Kingdom that is awarded by the Science Council through its Licensed member organisations. Holders of this qualification can use the post-nominal letters CSci. and a Chartered Chemist Chartered Chemist (CChem) is a chartered status awarded by the Royal Society of Chemistry (RSC) in the United Kingdom and by the Royal Australian Chemical Institute (RACI) in Australia. . He is Chairman of the INSIGHT High Throughput Technologies Faraday faraday /far·a·day/ (F ) (far´ah-da) the electric charge carried by one mole of electrons or one equivalent weight of ions, equal to 9.649 × 104coulombs. far·a·day n. Partnership, sponsored by the UK Government's Department of Trade and Industry The Department of Trade and Industry was a United Kingdom government department which was disbanded with the announcement of the creation of the Department for Business, Enterprise and Regulatory Reform on 28 June 2007[1]. and a Member of their Micro Nano Technology Executive Panel. He is also a member of the UK Engineering and Physics Science Research Council Nanotechnology Strategy Working Party. He holds an honorary Professorship from the University of Hull, UK and is currently a Visiting Scientist in Residence at the University of Cambridge, UK. Dr. Warrington's efforts in the field of automation and high throughput technologies have been recognized within the US and the UK life sciences industry. In January 2000, he was presented with the Association for Laboratory Automation Achievement Award. In November 2005, Dr. Warrington was awarded the Royal Society of Chemistry's Millennium Silver Medal for High throughput Drug Discovery Methodologies with the citation, "Distinguished for his pioneering work that led to the creation of the world's first 'compound factory' based on high throughput synthesis, and his leadership in the field of microfluidics for compound synthesis and screening." About Phoenix IP Ventures: An Intellectual Property Merchant Bank which works in partnership with life sciences companies to maximize the potential value of intellectual property based assets through equity investments, financial and transactional structuring, and/or licensing, Phoenix IPV works in collaboration with the venture capital and hedge fund hedge fund, in finance, a highly speculative, largely unregulated investment device. Originating in the 1950s, the funds "hedge" by offsetting "short" positions (borrowing a security and then selling it at a higher price before repaying the lender) against "long" communities, as appropriate, to scale its own proprietary investments in transactions identified and managed by the Firm. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion